Cooperative Agreements for Diabetes Control Programs

 

Diabetes Prevention and Control Programs (DPCPs) are funded by the CDC's Division of Diabetes Translation to address the following national level goals: 1) Prevent diabetes. 2) Prevent the complications, disabilities, and burden associated with diabetes. 3) Eliminate diabetes-related health disparities. 4) Maximize organizational capacity to achieve the National Diabetes Program goals. DPCPs aim to achieve system and population-level change and, ultimately, to improve health outcomes by coordinating and leveraging the efforts of the statewide diabetes community. They are responsible for establishing partnerships with key organizations in support of the national goals stated above, and for implementing and evaluating evidence-based interventions in three main areas: 1. Intervention #1: Improve quality of clinical care for populations with greatest diabetes burden and risk to improve control of A1c, blood pressure, and cholesterol, and to promote tobacco cessation. 2. Intervention #2: Increase access to sustainable self-management education and support services for populations with greatest diabetes burden and risk to improve control of A1c, blood pressure, and cholesterol, and to promote tobacco cessation. 3. Intervention #3: Increase use of lifestyle change programs that have achieved CDC recognition (or pending recognition) to prevent or delay onset of type 2 diabetes among people at high risk. Assist State and local health authorities and other health related organizations in controlling communicable diseases, chronic diseases and disorders and other preventable health conditions. Provide specific health surveillance using telephone and multi-mode survey methodologies for the behaviors of the general population that contribute to the occurrences and prevention of chronic diseases, injuries and other public health threats. The collection, analysis and dissemination of BRFSS data to state and territorial health department categorical programs is used for assessing trends, directing program planning, evaluating program priorities, developing policies and targeting relevant population groups.

Deleted 04/02/2020 (Archived.) 93.988 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Public Health Service Act, as amended, Section 317K, 42 U.S.C. 241(a); 42 U.S.C. 247b-12. Public Health Service Act, Section 301(a) 317(k)(3), Public Law USC-95-626. Public Health Service Act,Title 42,Part ,Section 243, 247B(k)(2). Eligible applicants are the official State and territorial health agencies of the United States, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, the Republic of Palau, and American Samoa. State health agencies will benefit. Any required credentials and/or documentation will be identified in the specific Notice of Funding Opportunity (NOFO) for this Assistance Listing. Preapplication coordination is not applicable. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any. Contact the headquarters or regional location, as appropriate for application deadlines From 3 to 4 months. Not applicable. Project period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government. Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity Announcements (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC. Cooperative Agreement funds may be used for costs associated with planning, implementing, and evaluating State based diabetes control programs. Cooperative Agreement funds may not be used for direct curative or rehabilitative services. Cooperative Agreement funds may also be used for health surveillance around BRFSS activities. Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials. In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching is voluntary. 25%. Matching funds are required from non-federal sources in the amount of not less than $1 for each $4 federal funds awarded to grantees. No matching funds are required for the Health Surveillance BRFSS program.

MOE requirements are not applicable to this assistance listing. Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award None/Not specified. Sheryl Heard
4770 Buford Highway, NE
Atlanta, GA 30341 USA
slh3@cdc.gov
Phone: 7704882855 http://www.cdc.gov 75-0958-0-1-550 (Cooperative Agreements) FY 22 FY 23 est $178,357,982.00; FY 24 est $178,357,982.00; FY 17$0.00; FY 18 est $0.00; FY 19 est $0.00; FY 16$0.00; - Component A: award range of $850,000-$1,250,000 Component B: award range of $750,000-$1,100,000 Component C: award range of $2,500,000-$3,300,000 Not applicable. Not applicable.